| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 51.37M | 32.99M | 24.89M | 22.10M | 13.55M | 13.76M |
| Gross Profit | 32.76M | 19.34M | 12.39M | 10.77M | 6.17M | 4.43M |
| EBITDA | 14.53M | 10.69M | 9.05M | 8.41M | 3.83M | 3.51M |
| Net Income | 1.59M | 1.63M | 2.65M | 6.00M | -3.90M | -4.68M |
Balance Sheet | ||||||
| Total Assets | 106.11M | 67.45M | 42.97M | 32.58M | 19.80M | 32.49M |
| Cash, Cash Equivalents and Short-Term Investments | 1.50M | 5.76M | 1.47M | 571.00K | 108.00K | 761.00K |
| Total Debt | 33.40M | 28.33M | 27.61M | 20.68M | 17.02M | 26.88M |
| Total Liabilities | 46.98M | 35.46M | 30.86M | 24.09M | 19.40M | 28.47M |
| Stockholders Equity | 59.13M | 31.99M | 12.12M | 8.49M | 398.00K | 4.02M |
Cash Flow | ||||||
| Free Cash Flow | -35.85M | -10.37M | -3.58M | -2.80M | -1.22M | 939.00K |
| Operating Cash Flow | 14.85M | 11.02M | 9.89M | 6.19M | 4.54M | 2.72M |
| Investing Cash Flow | -47.53M | -20.53M | -13.45M | -8.61M | 6.58M | 841.00K |
| Financing Cash Flow | 28.76M | 13.80M | 4.47M | 2.88M | -11.77M | -2.97M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | C$781.22M | 7.49 | 12.57% | 2.57% | 15.58% | 47.55% | |
71 Outperform | C$646.17M | 12.37 | 3.06% | ― | -8.13% | -28.00% | |
62 Neutral | C$286.00M | 22.63 | 3.44% | 6.19% | -8.58% | -98.92% | |
56 Neutral | C$619.05M | -12.07 | -2.94% | ― | -2.47% | -246.73% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
55 Neutral | C$533.56M | 1,049.06 | 3.11% | ― | 80.50% | 558.33% | |
48 Neutral | C$528.14M | 16.74 | 7.88% | 2.56% | 8.24% | -36.88% |